Market Tracker

12/19 4:08am ET

Allergan Inc (NYSE:AGN)

212.18
Data as of Dec 18
 +4.15 / +1.99%
Today’s Change
98.78
Today|||52-Week Range
214.66
+91.02%
Year-to-Date

Today’s Trading

Previous close208.03
Today’s open210.50
Day’s range209.55 - 213.61
Volume2,848,972
Average volume (3 months)3,160,328
Market cap$62.0B
Dividend yield0.09%
Data as of 12/18/2014

Growth & Valuation

Earnings growth (last year)+18.75%
Earnings growth (this year)+32.06%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+8.37%
P/E ratio49.6
Price/Sales5.24
Price/Book9.58

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+1.51+3.41%
ACTActavis+2.85+1.09%
VRXValeant Pharmaceutic...+3.00+2.14%
LLYEli Lilly and Co+2.17+3.09%
Data as of 12/18/2014

Financials

Next reporting dateFebruary 4, 2015
EPS forecast (this quarter)$1.83
Annual revenue (last year)$6.3B
Annual profit (last year)$1.3B
Net profit margin20.17%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
David E. I. Pyott
President
Douglas S. Ingram
Corporate headquarters
Irvine, California

Forecasts